The cambridge peanut allergy clinic: Real world safety and efficacy outcomes during oral immunotherapy with characterised peanut flour

被引：0
|
作者：
Clark, A. [1 ]
Zolkipli, Q. [1 ]
Ewan, P. [1 ]
机构：
[1] Cambridge Univ Hosp, Cambridge, England
来源：
ALLERGY | 2019年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
OA0022
引用
收藏
页码：15 / 16
页数：2
相关论文
共 50 条
  • [21] Outcomes of real-world use of FDA-approved peanut oral immunotherapy
    Gunderman, Lauren
    Bosworth, Jennifer
    Stadtler, Danielle
    Pongracic, Jacqueline
    Robison, Rachel
    Makhija, Melanie
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB34 - AB34
  • [22] Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety (2019)
    Chu, D. K.
    Wood, R. A.
    French, S.
    LANCET, 2019, 393 (10184): : 1936 - 1936
  • [23] Quality of life improves significantly after real-world oral immunotherapy for children with peanut allergy
    Blackman, Andrea C.
    Staggers, Kristen A.
    Kronisch, Lauren
    Davis, Carla M.
    Anagnostou, Aikaterini
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (02) : 196 - +
  • [24] Quality of Life Improves Significantly After Real-World Oral Immunotherapy for Children With Peanut Allergy
    Blackman, A. C.
    Staggers, K. A.
    Kronisch, L.
    Davis, C. M.
    Anagnostou, A.
    PEDIATRICS, 2021, 148 : S33 - S34
  • [25] Grass pollen allergy as an anaphylaxis cofactor during peanut oral immunotherapy
    Chua, Gilbert T.
    Chan, Edmond S.
    Soller, Lianne
    Cameron, Scott B.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (02) : 263 - 264
  • [26] Safety of Peanut Oral Immunotherapy in Preschoolers at a Pediatric Academic Food Allergy Center
    Vickery, Brian
    Horton, Codi
    Leef, Chelsea
    Bai, Shasha
    Ezhuthachan, Idil
    Lee, Tricia
    Lee, Gerald
    Rathkopf, Melinda
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB119 - AB119
  • [27] Efficacy and Safety of Epicutaneous Immunotherapy for Peanut Allergy in Subjects With and Without Atopic Dermatitis
    Davis, Carla M.
    Green, Todd David
    Lambert, Romain
    Fleischer, David
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB242 - AB242
  • [28] Real-world adoption of peanut oral immunotherapy in infants and toddlers
    Mustafa, S. Shahzad
    Capucilli, Peter
    Tuong, Linh-An
    Sanchez-Tejera, Denise
    Vadamalai, Karthik
    Ramsey, Allison
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (08):
  • [29] Efficacy, Safety, and Quality of Life in a Multicenter, Randomized, Placebo-Controlled Trial of Low-Dose Peanut Oral Immunotherapy in Children with Peanut Allergy
    Blumchen, Katharina
    Trendelenburg, Valerie
    Ahrens, Frank
    Gruebl, Armin
    Hamelmann, Eckard
    Hansen, Gesine
    Heinzmann, Andrea
    Nemat, Katja
    Holzhauser, Thomas
    Roeder, Martin
    Rosenfeld, Leonard
    Hartmann, Oliver
    Niggemann, Bodo
    Beyer, Kirsten
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (02): : 479 - +
  • [30] Bronchial hyperresponsiveness and asthma during oral immunotherapy for egg or peanut allergy in children
    Burman, Janne
    Palosuo, Kati
    Pelkonen, Anna
    Malmberg, Pekka
    Remes, Sami
    Kukkonen, Kaarina
    Makela, Mika J.
    CLINICAL AND TRANSLATIONAL ALLERGY, 2022, 12 (10)
12345